Ozempic in Singapore: What Patients Should Know

Ozempic is one of the most-searched medicine names in Singapore — usually by people who have read about weight loss, not diabetes. That gap between what the name is known for and what it is actually approved for is worth understanding, because it affects what a doctor can and cannot offer you.

What Ozempic is

Ozempic is a prescription medicine containing semaglutide, given as a weekly injection. This class of medicine has been in clinical use for type 2 diabetes since the mid-2000s, so the safety profile is well established. In Singapore it is registered for the treatment of type 2 diabetes — to help control blood sugar in adults whose diabetes is not adequately controlled by diet, exercise and other medicines.

It belongs to the GLP-1 receptor agonist class: medicines that copy a natural gut hormone involved in appetite and blood-sugar regulation. That class includes products approved for weight management at higher doses and products approved for diabetes at lower doses.

The distinction that matters

Search interest in Ozempic is overwhelmingly about weight. But:

• Ozempic is approved for diabetes, not for weight loss.
• Using a medicine outside its approved indication is called off-label use — it is not an approved weight-loss treatment, and promoting it as one is not something a responsible clinic does.
• For weight management, the appropriate conversation is about which treatments are approved for that purpose in Singapore, and whether any of them suit you.

That is the honest position, and it is why you will not find this clinic advertising it as a weight-loss product.

Why GLP-1 medicines attract so much attention

The class these medicines belong to has produced some of the most effective medical weight-management results ever recorded in trials — average losses of around 15% of body weight over 68 weeks in the main programme, against about 2–3% with lifestyle change alone. That is a genuine scientific advance, and it is why the news coverage is so intense — and why so many people arrive at the clinic asking about it. The local context matters too: MOH’s 2022 National Population Health Survey found 36.2% of Singaporeans aged 18–74 were overweight and 11.8% obese. The confusion arises because journalists describe the class using brand names — and those names belong to specific products with specific approvals.

If you want the science rather than the headlines, our GLP-1 guide and the evidence summary on semaglutide cover it in detail without the brand noise.

Why every route runs through a doctor

Ozempic is prescription-only in Singapore for good reason:

• It was prescribed for a specific indication by a doctor who knows your history.
• It has contraindications and interactions that need screening.
• It requires monitoring — dose build-up, tolerance, and follow-up bloods where relevant.
• Buying it from unverified sources is unsafe and against Singapore regulations.

For diabetes, that oversight is routine. For anyone seeking it for weight, the medical answer is different: an assessment to discuss treatments that are actually appropriate for that purpose.

If you are looking for weight treatment

Start with the assessment, not the product name. A doctor will review your history, measurements and health markers, tell you whether medical treatment is appropriate at all, and — if it is — which options are approved for weight management in Singapore and what the monitoring looks like.

That is how our doctor-led weight management programme works: assessment first, treatment only where appropriate, and no promises that the evidence does not support. If you are specifically interested in the class of medicines you have been reading about, the GLP-1 guide is the place to start.